Medical Management of Inflammatory Bowel Disease.
Surg Clin North Am
; 104(3): 657-671, 2024 Jun.
Article
em En
| MEDLINE
| ID: mdl-38677828
ABSTRACT
The past few decades have seen significant advancements in the medical management of both ulcerative colitis (UC) and Crohn's disease (CD). The previous dependence on steroids is no longer an acceptable strategy following the Food and Drug Administration approval for several new classes of medication. These medications include aminosalicylates, immunomodulators, biologics, and oral targeted small-molecule inhibitors. This article highlights several key trials and discusses modern treatment paradigms for both UC and CD based on disease severity.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Colite Ulcerativa
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article